Literature DB >> 1128607

Effect of oxandrolone treatment on the activity of lipoprotein lipase, hepatic lipase and phospholipase A1 of human postheparin plasma.

C Ehnholm, J K Huttunen, P J Kinnunen, T A Miettinen, E A Nikkilä.   

Abstract

The effect of a synthetic steroid, oxandrolone, on total postheparin plasma lipolytic activity, postherpain hepatic lipase activity, lipoprotein lipase and phospholipase A1 was studied in seven patients with hypertriglyceridemia. The mean total postheparin lipolytic activity increased 100 per cent during oxandrolone tratement (p smaller than 0.05). This change was caused mainly by postheparin hepatic lipase, whose activity increased on the average more than 2.5 times (p smaller than 0.001). The change in postheparin plasma-lipoprotein-lipase activity was insignificant. A highly significant correlation (r equals +0.87, p smaller than 0.01) was observed between the activities of postheparin hepatic lipase and phospholipase A1 before and during oxandrolone treatment. No relation was observed between serum triglyceride level and various postheparin lipase activities, or between the changes induced by oxandrolone in the level of serum lipids and the activities of postheparin lipases. We conclude that oxandrolone increases the activities of postheparin plasma hepatic lipase and phospholipase A1 but has little influence on lipoprotein lipase.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1128607     DOI: 10.1056/NEJM197506192922503

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  10 in total

Review 1.  The lipoprotein lipase system: new understandings.

Authors:  M H Tan
Journal:  Can Med Assoc J       Date:  1978-03-18       Impact factor: 8.262

Review 2.  Anabolic-androgenic steroid effects on endocrinology and lipid metabolism in athletes.

Authors:  M Alén; P Rahkila
Journal:  Sports Med       Date:  1988-12       Impact factor: 11.136

3.  Effect of Selective Androgen Receptor Modulator on Cholesterol Efflux Capacity, Size, and Subspecies of HDL Particles.

Authors:  Wen Guo; Karol M Pencina; Jeremy D Furtado; Frank M Sacks; Tomas Vaisar; Ming Cheng; Allan D Sniderman; Stephanie T Page; Shalender Bhasin
Journal:  J Endocr Soc       Date:  2022-06-28

Review 4.  Recent developments in the toxicology of anabolic steroids.

Authors:  S Graham; M Kennedy
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

5.  Relationship between lipoprotein lipase activity and plasma sex steroid level in obese women.

Authors:  P H Iverius; J D Brunzell
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

6.  Sex steroid modulation of fatty acid utilization and fatty acid binding protein concentration in rat liver.

Authors:  R K Ockner; N Lysenko; J A Manning; S E Monroe; D A Burnett
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

7.  Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase.

Authors:  D M Applebaum; A P Goldberg; O J Pykälistö; J D Brunzell; W R Hazzard
Journal:  J Clin Invest       Date:  1977-04       Impact factor: 14.808

Review 8.  The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety.

Authors:  Rhonda Orr; Maria Fiatarone Singh
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL.

Authors:  Patrick T Reeves; David N Herndon; Jessica D Tanksley; Kristofer Jennings; Gordon L Klein; Ronald P Mlcak; Robert P Clayton; Nancy N Crites; Joshua P Hays; Clark Andersen; Jong O Lee; Walter Meyer; Oscar E Suman; Celeste C Finnerty
Journal:  Shock       Date:  2016-04       Impact factor: 3.454

Review 10.  Clinical pharmacokinetics of heparin.

Authors:  J W Estes
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.